Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Olga, Martelli"'
Autor:
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio, Elena Collovà, Federica Bertolini, Fausto Petrelli, Alessandra Cassano, Rita Chiari, Francesca Zanelli, Salvatore Pisconti, Isabella Vittimberga, Antonietta Letizia, Andrea Misino, Angela Gernone, Erminio Bonizzoni, Sara Pilotto, Sabino De Placido, Emilio Bria
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract We demonstrated the non-inferiority of a dexamethasone (DEX)-sparing (single-dose) regimen with NEPA, a netupitant/palonosetron fixed combination, for preventing chemotherapy-induced nausea and vomiting (CINV) caused by cisplatin. This pre-p
Externí odkaz:
https://doaj.org/article/eaf50c49a3ae4f15ab666dbba2732470
Autor:
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio, Elena Collovà, Federica Bertolini, Fausto Petrelli, Alessandra Cassano, Rita Chiari, Francesca Zanelli, Salvatore Pisconti, Isabella Vittimberga, Antonietta Letizia, Andrea Misino, Angela Gernone, Erminio Bonizzoni, Sara Pilotto, Sabino De Placido, Emilio Bria
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background The non-inferiority of dexamethasone (DEX) on day 1, with or without low-dose DEX on days 2 and 3, combined with oral NEPA (netupitant/palonosetron), compared with the guideline-consistent use of DEX was demonstrated in cisplatin.
Externí odkaz:
https://doaj.org/article/4ace3d1c9d1743c2a4939c50f0a7fa2e
Autor:
Fabrizio Tabbò, Lucia Anna Muscarella, Elisa Gobbini, Domenico Trombetta, Stefano Castellana, Angelica Rigutto, Domenico Galetta, Evaristo Maiello, Olga Martelli, Marcello Tiseo, Vieri Scotti, Laura Ghilardi, Vanesa Gregorc, Concetta Sergi, Sara Pilotto, Alessandro Del Conte, Federico Cappuzzo, Diego Cortinovis, Giorgia Osman, Claudia Bareggi, Massimo Di Maio, Antonio Rossi, Giulio Rossi, Emilio Bria, Marco Volante, Giorgio Vittorio Scagliotti, Paolo Graziano, Silvia Novello, Luisella Righi
Anaplastic lymphoma kinase (ALK) fusions identify a limited subset of non-small cell lung cancer (NSCLC) patients, whose therapeutic approach have been radically changed in recent years. However, diagnostic procedures and clinical-radiological respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66632411577a3a24597a3e96ac6f796a
https://hdl.handle.net/2318/1878601
https://hdl.handle.net/2318/1878601
Autor:
Gabriele, Minuti, Alessio, Stefani, Silvia, Carpano, Ettore, D'Argento, Raffaele, Giusti, Olga, Martelli, Giulio, Metro, Alain J, Gelibter, Gian Carlo, Antonini Cappellini, Annamaria, Carta, Giovanni Maria, Fadda, Fabrizio, Nelli, Serena, Ricciardi, Marco, Russano, Emilio, Bria, Federico, Cappuzzo
Publikováno v:
Recenti progressi in medicina. 112(10)
Small cell lung cancer (SCLC) is an aggressive disease, difficult to treat. There have been no significant therapeutic advances over platinum and etoposide chemotherapy in the last 20 years until the introduction of immunotherapy. In 2020 atezolizuma
Autor:
Federica Bertolini, Antonietta Letizia, Simona Carnio, Emilio Bria, A. Misino, Olga Martelli, Salvatore Pisconti, Sabino De Placido, Luigi Cavanna, F. Zanelli, Alessio Aligi Cogoni, Fausto Petrelli, Sara Pilotto, Isabella Vittimberga, Luigi Celio, Elena Collovà, Angela Gernone, Erminio Bonizzoni, Rita Chiari, Alessandra Cassano, Diego Cortinovis
Publikováno v:
The Oncologist
Background To reduce the overall exposure to dexamethasone (DEX) in patients receiving cisplatin‐based chemotherapy, we evaluated the noninferiority of DEX on day 1, with or without low‐dose DEX on days 2 and 3, combined with an oral fixed‐dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0ad4f3eea04f4ea204d020fd8c0049
http://hdl.handle.net/11588/890574
http://hdl.handle.net/11588/890574
Autor:
Fabrizio, Nelli, Maria Agnese, Fabbri, Luca, Moscetti, Isabella, Sperduti, Teresa, Gamucci, Giovanni, Mansueto, Carlo, Signorelli, Enrico, Cortesi, Olga, Martelli, Clara, Natoli, Francesco, Angelini, Enzo Maria, Ruggeri
Publikováno v:
Recenti progressi in medicina. 111(12)
Pemetrexed maintenance significantly improved progression-free survival (PFS) and overall survival (OS) in advanced nonsquamous non-small-cell lung cancer (NSCLC) patients not progressing after induction chemotherapy.This study is aimed at examine th
Autor:
Francesco Equitani, Clara Nervi, Olga Martelli, Oreste Bagni, Concetta Potenza, Riccardo Pirisino, Luca Filippi, Ilaria Proietti
Publikováno v:
Expert review of molecular diagnostics. 20(12)
Introduction: Only 20-40% of patients respond to therapy with immune checkpoint inhibitors (ICIs). Therefore, the early identification of subjects that can benefit from such therapeutic regimen is mandatory. Areas covered: The immunobiological mechan
Autor:
Giuseppina Rosaria Rita Ricciardi, Antonio Galvano, Francesco Pantano, Alain Gelibter, Michele Aieta, Daniele Santini, Marco Russano, Giulia Pasquini, Alessandro Russo, Lorenzo Calvetti, Giovanni Mansueto, Giuseppe Aprile, Giuseppe Tonini, Enrico Vasile, Sandro Barni, Marco Imperatori, Fausto Petrelli, Tindara Franchina, Michele Maio, Elisa Roca, Luana Calabrò, Maria Rita Migliorino, Daniela Iacono, Olga Martelli, Silvia Quadrini, Salvatore Intagliata, Vincenzo Adamo, Mario Occhipinti, Alfredo Falcone, Antonio Russo, Alfredo Berruti
Introduction: Immune checkpoint inhibitors have provided substantial benefit in non-small cell lung cancer (NSCLC) with unprecedented results in terms of survival. However, the identification of reliable predictive biomarkers to these agents is lacki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c230a8687a20374423c1bcc7d7f441
http://hdl.handle.net/11392/2492539
http://hdl.handle.net/11392/2492539
Autor:
Bianca D. Santomasso, Mauro Minelli, Raffaele Iorio, Mario Sabatelli, Olga Martelli, Francesca Pini, Daniela Bernardo, Tommaso Verdolotti
Publikováno v:
Integrative Molecular Medicine. 7
Autor:
Francesco Passiglia, Michele Aieta, Marco Imperatori, Giovanni Mansueto, Marco Russano, Alfredo Berruti, Giulia Pasquini, Daniele Santini, Elisa Roca, Tindara Franchina, Lorenzo Calvetti, Antonio Galvano, Anna Maria Di Giacomo, Iacopo Fioroni, Giuseppe Aprile, Daniela Iacono, Alessio Cortellini, Sandro Barni, Olga Martelli, Luana Calabrò, Michele Maio, Alain Gelibter, Maria Rita Migliorino, Bruno Vincenzi, Alessandro Russo, Corrado Ficorella, Olga Venditti, Silvia Quadrini, Salvatore Intagliata, Enrico Vasile, Giuseppe Tonini, Fausto Petrelli, Vincenzo Adamo, Alfredo Falcone, Mario Occhipinti, Antonio Russo, Andrea Napolitano, Francesco Pantano
Background: Immune-checkpoint inhibitors have radically changed the treatment landscape of Non-Small-Cell Lung Cancer (NSCLC). It is still unclear whether specific clinical characteristics might identify those patients benefiting from immunotherapy m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78b5be2e8e2810f947ef83391c385b04
http://hdl.handle.net/11573/1484803
http://hdl.handle.net/11573/1484803